|
|
Volumn 5, Issue 2, 2004, Pages 112-115
|
|
Adherence and HIV drug resistance
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
INDINAVIR;
LAMIVUDINE;
LOPINAVIR PLUS RITONAVIR;
NEVIRAPINE;
STAVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CLINICAL TRIAL;
DRUG POTENCY;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MEDICAL SOCIETY;
MORTALITY;
NOTE;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SIDE EFFECT;
TREATMENT FAILURE;
UNITED STATES;
VIRUS INHIBITION;
VIRUS REPLICATION;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
DRUG RESISTANCE;
HIV INFECTIONS;
HUMANS;
PATIENT COMPLIANCE;
TREATMENT FAILURE;
|
|
EID: 2542515344
PISSN: 15284336
EISSN: None
Source Type: Journal
DOI: 10.1310/N53E-1930-NJMW-GL7C Document Type: Note |
|
Times cited : (10)
|
|
References (0)
|